Clinical Trials Logo
  1. Home
  2. Ulcers
  3. NCT00701974

Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers

Ulcers Clinical Trial

Official title:
Study of Non Inferiority of Product Kollagenase ®, Manufactured by Laboratory Cristália When Compared With Iruxol ®, Manufactured by Abbott Laboratory, in the Treatment of Cutaneous Ulcers

Clinical Trial Summary

Skin ulcers can be defined as open injuries, loss of substances with the skin or mucous tissue, caused by disintegration and tissue necrosis. Chronic skin ulcer is any injury that heal in a period not less than 6 weeks. Several etiological causes for the emergence of skin ulcers. Around 73% are venous, arterial are 8%, 3% are diabetic, 2% are traumatic and 14% are from other causes. Clinical studies show that collagenase is an effective drug and presents high tolerabildade in the treatment of ulcerative burns and injuries of various etiologies. Evidence show statistically significant reduction of inflammation, the formation of granulation tissue, decrease in injuries and reepitelization.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00701974
Study type Interventional
Source Azidus Brasil
Contact
Status Suspended
Phase Phase 2/Phase 3
Start date February 2008
Completion date February 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT01214811 - Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Phase 3
Terminated NCT00700154 - Insulin Infusion Diabetes Ulcer N/A
Completed NCT01138436 - A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers Phase 2
Completed NCT01548378 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia Phase 2
Completed NCT01942941 - Peripheral Vascular Disease and Nerve Stimulation N/A
Completed NCT00718978 - Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS) N/A
Completed NCT00951080 - SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds N/A
Completed NCT01474109 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Terminated NCT01474122 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Completed NCT01439581 - Utility of Interface Pressure Mapping N/A
Completed NCT00597818 - Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury Phase 2
Completed NCT00189540 - Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers Phase 2
Recruiting NCT04275323 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) Phase 3
Recruiting NCT04274049 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) Phase 3
Completed NCT00688428 - Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination Phase 1